{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:50:55Z","timestamp":1791046255388,"version":"4.1.0"},"reference-count":34,"publisher":"American Association for Cancer Research (AACR)","issue":"9","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Two recent clinical trials have shown that the placenta growth factor (PlGF) is up-regulated after bevacizumab treatment in colorectal cancer and after SU11248 treatment in metastatic renal cell carcinoma. The regulation of expression for the vascular endothelial growth factor (VEGF) has been well documented in human tumors; however, the data for PlGF are lacking. We investigated the epigenetic regulation of PlGF and correlated the results with clinicopathologic features. We used plgf promoter analysis, cDNA microarray, immunohistochemistry, and Northern blot analysis to determine the expression level of PlGF in 22 human lung carcinoma and 11 colorectal tumors and in 12 cell lines. Sodium bisulfite modification of genomic DNA followed by methylation-specific PCR (MSP) and sequencing were used to determine the methylation status of the PlGF promoter. Treatments with 5-aza-2\u2032-deoxycytidine and trichostatin A (TSA) were used to reactivate PlGF expression. Significance analysis showed that PlGF expression level was low in human lung and colorectal tumor tissues and in cell lines. PlGF gene promoter was hypermethylated. Treatment with the demethylating agent 5-Aza-dC restored PlGF transcript expression in the lung and colon carcinoma cell lines. By combining the results from cDNA microarray, immunohistochemistry, and MSP, we report, for the first time, that the PlGF gene promoter is methylated, and methylation may be one of the mechanisms that contributes to the low PlGF expression level in human lung and colorectal tumor tissues and cell lines. (Mol Cancer Res 2007;5(9):873\u201380)<\/jats:p>","DOI":"10.1158\/1541-7786.mcr-06-0141","type":"journal-article","created":{"date-parts":[[2007,8,18]],"date-time":"2007-08-18T00:40:00Z","timestamp":1187397600000},"page":"873-880","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Down-Regulation of Placenta Growth Factor by Promoter Hypermethylation in Human Lung and Colon Carcinoma"],"prefix":"10.1158","volume":"5","author":[{"given":"Lei","family":"Xu","sequence":"first","affiliation":[{"name":"Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh K.","family":"Jain","sequence":"additional","affiliation":[{"name":"Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,9,12]]},"reference":[{"key":"2022060706330344200_BIB1","doi-asserted-by":"crossref","unstructured":"Takahashi H, Shibuya M. The vascular endothelial growth factor (VEGF)\/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci (Lond)\u20082005;109:227\u201341.","DOI":"10.1042\/CS20040370"},{"key":"2022060706330344200_BIB2","doi-asserted-by":"crossref","unstructured":"Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev\u20081997;18:4\u201325.","DOI":"10.1210\/edrv.18.1.0287"},{"key":"2022060706330344200_BIB3","doi-asserted-by":"crossref","unstructured":"Dvorak HF. Vascular permeability factor\/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol\u20082002;20:4368\u201380.","DOI":"10.1200\/JCO.2002.10.088"},{"key":"2022060706330344200_BIB4","doi-asserted-by":"crossref","unstructured":"Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A\u20081991;88:9267\u201371.","DOI":"10.1073\/pnas.88.20.9267"},{"key":"2022060706330344200_BIB5","doi-asserted-by":"crossref","unstructured":"Carmeliet P, Moons L, Luttun A, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med\u20082001;7:575\u201383.","DOI":"10.1038\/87904"},{"key":"2022060706330344200_BIB6","doi-asserted-by":"crossref","unstructured":"Autiero M, Waltenberger J, Communi D, et al. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med\u20082003;9:936\u201343.","DOI":"10.1038\/nm884"},{"key":"2022060706330344200_BIB7","doi-asserted-by":"crossref","unstructured":"Luttun A, Tjwa M, Moons L, et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med\u20082002;8:831\u201340.","DOI":"10.1038\/nm731"},{"key":"2022060706330344200_BIB8","doi-asserted-by":"crossref","unstructured":"Eriksson A, Cao R, Pawliuk R, et al. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1\/VEGF heterodimers. Cancer Cell\u20082002;1:99\u2013108.","DOI":"10.1016\/S1535-6108(02)00028-4"},{"key":"2022060706330344200_BIB9","doi-asserted-by":"crossref","unstructured":"Bjorndahl M, Cao R, Eriksson A, Cao Y. Blockage of VEGF-induced angiogenesis by preventing VEGF secretion. Circ Res\u20082004;94:1443\u201350.","DOI":"10.1161\/01.RES.0000129194.61747.bf"},{"key":"2022060706330344200_BIB10","doi-asserted-by":"crossref","unstructured":"Xu L, Cochran D, Tong RT, et al. PlGF inhibits tumor growth, angiogenesis and metastasis by depleting VEGF homodimers in orthotopic mouse models. Cancer Res\u20082006;66:3971\u20137.","DOI":"10.1158\/0008-5472.CAN-04-3085"},{"key":"2022060706330344200_BIB11","unstructured":"Maglione D, Guerriero V, Viglietto G, et al. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. Oncogene\u20081993;8:925\u201331."},{"key":"2022060706330344200_BIB12","doi-asserted-by":"crossref","unstructured":"Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med\u20082003;9:669\u201376.","DOI":"10.1038\/nm0603-669"},{"key":"2022060706330344200_BIB13","unstructured":"Viglietto G, Maglione D, Rambaldi M, et al. Upregulation of vascular endothelial growth factor (VEGF) and down-regulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines. Oncogene\u20081995;11:1569\u201379."},{"key":"2022060706330344200_BIB14","unstructured":"Viglietto G, Romano A, Maglione D, et al. Neovascularization in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta-derived growth factor. Oncogene\u20081996;13:577\u201387."},{"key":"2022060706330344200_BIB15","unstructured":"Hatva E, Bohling T, Jaaskelainen J, Persico MG, Haltia M, Alitalo K. Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas. Am J Pathol\u20081996;148:763\u201375."},{"key":"2022060706330344200_BIB16","doi-asserted-by":"crossref","unstructured":"Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature\u20081992;359:845\u20138.","DOI":"10.1038\/359845a0"},{"key":"2022060706330344200_BIB17","unstructured":"Takahashi A, Sasaki H, Kim SJ, et al. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res\u20081994;54:4233\u20137."},{"key":"2022060706330344200_BIB18","doi-asserted-by":"crossref","unstructured":"Wei SC, Tsao PN, Yu SC, et al. Placenta growth factor expression is correlated with survival of patients with colorectal cancer. Gut\u20082005;54:666\u201372.","DOI":"10.1136\/gut.2004.050831"},{"key":"2022060706330344200_BIB19","doi-asserted-by":"crossref","unstructured":"Zhang L, Chen J, Ke Y, Mansel RE, Jiang WG. Expression of Placenta growth factor (PlGF) in non\u2013small cell lung cancer (NSCLC) and the clinical and prognostic significance. World J Surg Oncol\u20082005;3:68\u201380.","DOI":"10.1186\/1477-7819-3-68"},{"key":"2022060706330344200_BIB20","doi-asserted-by":"crossref","unstructured":"Willett CG, Boucher Y, Duda DG, et al. Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. J Clin Oncol\u20082005;23:8136\u20139.","DOI":"10.1200\/JCO.2005.02.5635"},{"key":"2022060706330344200_BIB21","doi-asserted-by":"crossref","unstructured":"Motzer RJ, Michaelson MD, Redman BG, et al. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. J Clin Oncol\u20082006;24:16\u201324.","DOI":"10.1200\/JCO.2005.02.2574"},{"key":"2022060706330344200_BIB22","doi-asserted-by":"crossref","unstructured":"Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet\u20082006;7:21\u201333.","DOI":"10.1038\/nrg1748"},{"key":"2022060706330344200_BIB23","unstructured":"Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD. Aberrant promoter methylation of multiple genes in non\u2013small cell lung cancers. Cancer Res\u20082001;61:249\u201355."},{"key":"2022060706330344200_BIB24","doi-asserted-by":"crossref","unstructured":"Lee S, Hwang KS, Lee HJ, Kim JS, Kang GH. Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia. Lab Invest\u20082004;84:884\u201393.","DOI":"10.1038\/labinvest.3700108"},{"key":"2022060706330344200_BIB25","doi-asserted-by":"crossref","unstructured":"Lapchak PH, Melter M, Pal S, et al. CD40-induced transcriptional activation of vascular endothelial growth factor involves a 68-bp region of the promoter containing a CpG island. Am J Physiol Renal Physiol\u20082004;287:F512\u201320.","DOI":"10.1152\/ajprenal.00070.2004"},{"key":"2022060706330344200_BIB26","doi-asserted-by":"crossref","unstructured":"Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology\u20082005;69 Suppl 3:4\u201310.","DOI":"10.1159\/000088478"},{"key":"2022060706330344200_BIB27","doi-asserted-by":"crossref","unstructured":"Dvorak HF. Angiogenesis: update 2005. J Thromb Haemost\u20082005;3:1835\u201342.","DOI":"10.1111\/j.1538-7836.2005.01361.x"},{"key":"2022060706330344200_BIB28","unstructured":"Green CJ, Lichtlen P, Huynh NT, et al. Placenta growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1. Cancer Res\u20082001;61:2696\u2013703."},{"key":"2022060706330344200_BIB29","doi-asserted-by":"crossref","unstructured":"Lash GE, Taylor CM, Trew AJ, et al. Vascular endothelial growth factor and placental growth factor release in cultured trophoblast cells under different oxygen tensions. Growth Factors\u20082002;20:189\u201396.","DOI":"10.1080\/0897719021000069560"},{"key":"2022060706330344200_BIB30","doi-asserted-by":"crossref","unstructured":"Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer\u20082002;2:647\u201356.","DOI":"10.1038\/nrc883"},{"key":"2022060706330344200_BIB31","doi-asserted-by":"crossref","unstructured":"Nan X, Ng HH, Johnson CA, et al. Transcriptional repression by the methyl-CpG\u2013binding protein MeCP2 involves a histone deacetylase complex. Nature\u20081998;393:386\u20139.","DOI":"10.1038\/30764"},{"key":"2022060706330344200_BIB32","doi-asserted-by":"crossref","unstructured":"Jones PL, Veenstra GJ, Wade PA, et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet\u20081998;19:187\u201391.","DOI":"10.1038\/561"},{"key":"2022060706330344200_BIB33","doi-asserted-by":"crossref","unstructured":"Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet\u20081999;21:103\u20137.","DOI":"10.1038\/5047"},{"key":"2022060706330344200_BIB34","unstructured":"Xu L, Fidler IJ. Acidic pH-induced elevation in interleukin 8 expression by human ovarian carcinoma cells. Cancer Res\u20082000;60:4610\u20136."}],"container-title":["Molecular Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/mcr\/article-pdf\/5\/9\/873\/3141223\/873.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/mcr\/article-pdf\/5\/9\/873\/3141223\/873.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T08:21:53Z","timestamp":1654590113000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/mcr\/article\/5\/9\/873\/234163\/Down-Regulation-of-Placenta-Growth-Factor-by"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,1]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2007,9,12]]},"published-print":{"date-parts":[[2007,9,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1541-7786.mcr-06-0141","relation":{},"ISSN":["1541-7786","1557-3125"],"issn-type":[{"value":"1541-7786","type":"print"},{"value":"1557-3125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,1]]}}}